Reaction Details Report a problem with these data
Target
Cytochrome P450 2C8
Ligand
BDBM295665
Substrate
n/a
Meas. Tech.
ChEMBL_2240004 (CHEMBL5153900)
IC50
>10000±n/a nM
Citation
 Hanan, EJ; Braun, MG; Heald, RA; MacLeod, C; Chan, C; Clausen, S; Edgar, KA; Eigenbrot, C; Elliott, R; Endres, N; Friedman, LS; Gogol, E; Gu, XH; Thibodeau, RH; Jackson, PS; Kiefer, JR; Knight, JD; Nannini, M; Narukulla, R; Pace, A; Pang, J; Purkey, HE; Salphati, L; Sampath, D; Schmidt, S; Sideris, S; Song, K; Sujatha-Bhaskar, S; Ultsch, M; Wallweber, H; Xin, J; Yeap, S; Young, A; Zhong, Y; Staben, ST Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3K?. J Med Chem 65:16589-16621 (2022) [PubMed] 
Target
Name:
Cytochrome P450 2C8
Synonyms:
CP2C8_HUMAN | CYP2C8 | CYPIIC8 | Cytochrome P450 2C8 (CYP2C8) | P450 IIC2 | P450 MP-12/MP-20 | P450 form 1 | S-mephenytoin 4-hydroxylase
Type:
Protein
Mol. Mass.:
55839.23
Organism:
Homo sapiens (Human)
Description:
P10632
Residue:
490
Sequence:
MEPFVVLVLCLSFMLLFSLWRQSCRRRKLPPGPTPLPIIGNMLQIDVKDICKSFTNFSKVYGPVFTVYFGMNPIVVFHGYEAVKEALIDNGEEFSGRGNSPISQRITKGLGIISSNGKRWKEIRRFSLTTLRNFGMGKRSIEDRVQEEAHCLVEELRKTKASPCDPTFILGCAPCNVICSVVFQKRFDYKDQNFLTLMKRFNENFRILNSPWIQVCNNFPLLIDCFPGTHNKVLKNVALTRSYIREKVKEHQASLDVNNPRDFIDCFLIKMEQEKDNQKSEFNIENLVGTVADLFVAGTETTSTTLRYGLLLLLKHPEVTAKVQEEIDHVIGRHRSPCMQDRSHMPYTDAVVHEIQRYSDLVPTGVPHAVTTDTKFRNYLIPKGTTIMALLTSVLHDDKEFPNPNIFDPGHFLDKNGNFKKSDYFMPFSAGKRICAGEGLARMELFLFLTTILQNFNLKSVDDLKNLNTTAVTKGIVSLPPSYQICFIPV
  
Inhibitor
Name:
BDBM295665
Synonyms:
(S)-2-((2-((S)-4-(difluoromethyl)- 2-oxooxazolidin-3-yl)-5,6- dihydrobenzo[f]imidazo[1,2- d][1,4]oxazepin-9- yl)amino)propanamide | US10112932, Compound 101 | US10851091, Compound 101
Type:
Small organic molecule
Emp. Form.:
C18H19F2N5O4
Mol. Mass.:
407.3714
SMILES:
C[C@H](Nc1ccc2-c3nc(cn3CCOc2c1)N1[C@@H](COC1=O)C(F)F)C(N)=O |r|
Structure:
Search PDB for entries with ligand similarity: